학술논문
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: A randomised phase 2 study
Document Type
Article
Author
Source
In: The Lancet Oncology . (The Lancet Oncology, 1 October 2014, 15(11):1207-1214)
Subject
Language
English
ISSN
14745488
14702045
14702045